Status:
UNKNOWN
Establishment of Clinical Staging of Chronic Pancreatitis Based on Histopathology of Pancreatic Duct Biopsy
Lead Sponsor:
Changhai Hospital
Conditions:
Chronic Pancreatitis
Eligibility:
All Genders
18-70 years
Brief Summary
This study intends to establish the clinical staging of chronic pancreatitis based on histopathology through pancreatic duct biopsy technology.
Detailed Description
Chronic pancreatitis (CP) is an inflammatory disease that can causes progressive fibrosis of pancreatic tissue and eventually leads to damage of pancreatic exocrine and endocrine. According to statist...
Eligibility Criteria
Inclusion
- Patients with chronic pancreatitis or idiopathic recurrent acute pancreatitis;
- In line with the indications for ERCP treatment.
Exclusion
- suspected to have malignant tumors;
- history of pancreatic surgery or gastrojejunostomy (Billroth II);
- bile duct stricture secondary to cholangitis or chronic pancreatitis;
- acute pancreatitis exacerbation or acute exacerbation of chronic pancreatitis;
- coagulation dysfunction (INR≥1.5 or platelet count≤50×10\^9/L);
- pregnant or breastfeeding women;
- patients who refused to participate in the study.
Key Trial Info
Start Date :
March 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05352932
Start Date
March 9 2022
End Date
December 1 2022
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, China, 200433